Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa for reducing intraoperative blood loss during necrosectomy in severe acute pancreatitis
ChiCTR-TRC-13003895Phase 4Completed
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of coagulation factor VIIa in acute pancreatitis (AP) and necrotizing pancreatitis (ANP) (2 arms), sponsored by General Hospital of Eastern Military Command. Primary endpoints: Prothrombin time, Activated partial thromboplastin time and 3 more. Started Jan 2008; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
acute pancreatitis (AP)necrotizing pancreatitis (ANP)
Beyond the preview
Go deeper on ChiCTR-TRC-13003895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003895.